logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
T

Timothy F. Burns

pennsylvania commonwealth system of higher education (pcshe)
H指数:41
被引数:9,197

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase 2 Study of Cabozantinib (XL184) with Nivolumab and Ipilimumab for the Treatment of Poorly Differentiated Neuroendocrine Carcinomas (ETCTN10315)

卡博替尼（XL184）联合纳武利尤单抗和伊匹木单抗治疗低分化神经内分泌癌的2期研究（ETCTN10315）

The Oncologist
IF0
2026-04-100
OA
Adel Mandl; Ruizhe Chen; Satya Das; Jonathan R Strosberg; Anup Kasi; Bhavana Konda; Daneng Li; Timothy F Burns; Aman Chauhan; Kristen K Ciombor; Farshid Dayyani; Tanya Dorff; James P Ohr; Bhaumik B Patel; Vineeth Sukrithan; Heloisa P Soares; Kang Chen; Stephen V Liu; Anteneh A Tesfaye; Michael A Carducci; Jan H Beumer; null
SUNRAY-01 trial protocol: an innovative study design of olomorasib and pembrolizumab with or without chemotherapy in KRAS G12C NSCLC

SUNRAY-01试验方案：一项关于olomorasib和pembrolizumab联合或不联合化疗治疗KRAS G12C NSCLC的创新性研究设计

Future Oncology
IF2.6
2026-04-060
PRE
Solange Peters; Maximilian Hochmair; Kathryn C. Arbour; Luis Paz-Ares Rodriguez; Martin Reck; Ticiana Leal; Colin R. Lindsay; Lu Shun; William Nassib William; Alexander I. Spira; Joshua K. Sabari; Bjørn Henning Grønberg; Makoto Nishio; Timothy F. Burns; Nicolas Girard; Frederico Capuzzo; Alyson Merced; Nicolas Fasnacht; Carla Visseren-Grul; Marcelo V. Negrao
Pan-tumor activity of olomorasib, a next-generation KRAS G12C inhibitor in KRAS G12C-mutant advanced solid tumors: a first-in-human study

奥罗玛西布（olomorasib）对KRAS G12C突变型晚期实体瘤的泛瘤活性：一项首次人体研究

Nature Communications
IF15.7
2026-03-120
OAAI
Yonina R. Murciano-Goroff; Antoine Hollebecque; Rebecca S. Heist; Philippe A. Cassier; Ji-Youn Han; So Yeon Kim; Joshua K. Sabari; Diego Tosi; Adrian Sacher; Timothy F. Burns; Toshio Shimizu; Natraj Reddy Ammakkanavar; Alexander Spira; Carlos Gomez-Roca; Amita Patnaik; Rasha Cosman; J. Nicholas Bodor; Misako Nagasaka; Arthur Xintian You; Samuel C. McNeely; Raimund Peter; Aaron Fink; Aaron Chen; Geoffrey R. Oxnard; Melinda D. Willard; Yasutoshi Kuboki; Takafumi Koyama
MET alterations are enriched in lung adenocarcinoma brain metastases, defining a distinct biologic subtype

MET基因突变在肺腺癌脑转移中富集，定义了一种独特的生物学亚型

Journal of Clinical Investigation
IF13.6
2026-02-160
OA
Burns, Timothy F.; Dacic, Sanja; Chakka, Anish; Miller, Ethan; Velez, Maria A.; Somasundaram, Ashwin; Bhattacharya, Saveri; Gaither-Davis, Autumn; Devadassan, Princey; Jin, Jingxiao; Kumar, Vinod; Pennathur, Arjun; Xiu, Joanne; Oberley, Matthew; Glantz, Michael J.; Aulakh, Sonikpreet; Chandran, Uma R.; Bao, Riyue; Tatsuoka, Curtis; Stabile, Laura P.
Efficacy and Safety of Olomorasib in Combination with Pembrolizumab in Treatment of Patients with KRAS G12C-Mutant Advanced NSCLC

奥罗莫西布与帕博利珠单抗联合治疗KRAS G12C突变型晚期非小细胞肺癌的疗效与安全性

Journal of Thoracic Oncology
IF20.8
2025-11-290
PRE
Timothy F. Burns; Natraj Reddy Ammakkanavar; Antoine Hollebecque; Dae Ho Lee; Takafumi Koyama; Philippe A. Cassier; Antoine Italiano; Ji-Youn Han; Nimit Singhal; Shinji Takeuchi; Rebecca S. Heist; Dustin Deming; Alexander Spira; Quincy Chu; Adrian Sacher; Yutaka Fujiwara; Michael J. Chisamore; Arthur Xintian You; Samuel C. McNeely; Aaron Fink
Phase 1 clinical trial of the ataxia telangiectasia and Rad3-related inhibitor berzosertib with irinotecan in patients with advanced solid tumors (ETCTN 9938)

I期临床试验：评估ataxia telangiectasia和Rad3-related抑制剂berzosertib联合伊立替康治疗晚期实体瘤患者的疗效（ETCTN 9938）

Cancer
IF5.1
2025-10-290
PRE
Liza C. Villaruz MD; Jingxiao Jin MD; Hong Wang PhD; James J. Lee MD, PhD; Jason J. Luke MD; John C. Rhee MD; Saiama N. Waqar MD; Geoffrey I. Shapiro MD, PhD; James Cleary MD, PhD; Diwakar Davar MD; Timothy F. Burns MD, PhD; Rashmi Verma MD; Manik Amin MD; Leonard Appleman MD, PhD; Kristen K. Ciombor MD; Elizabeth J. Davis MD; Jonathan W. Riess MD; E. Claire Dees MD; Edward J. Kim MD, PhD; Dana Cardin MD; Jianxia Guo PhD; Susan M. Christner BS; Joshua Deppas MS; Angelina M. Parise BS; John C. Schmitz PhD; Bella S. Guerrouahen PhD; Michael Suchko BS; Alejandro Contreras MD, PhD; Li Li PhD; Katherine V. Ferry-Galow PhD; Ting-Chia Chang MS; Shahanawaz Jiwani MD, PhD; Christopher J. Bakkenist PhD; Edward Chu MD; Steven D. Gore MD; Jan H. Beumer PharmD, PhD

研究方向

暂未获取到该数据
L
Laura P. Stabile
H 指数:38论文数:183被引数:4,363
P
Phuoc T. Tran
H 指数:67论文数:732被引数:1.5万
Z
Zachary A. Yochum
H 指数:7论文数:57被引数:409
E
Eric H.‐B. Huang
H 指数:12论文数:55被引数:659
S
Suman Chatterjee
H 指数:7论文数:13被引数:947
W
Wafik S. El‐Deiry
H 指数:120论文数:1,508被引数:8.7万
C
Charles M. Rudin
H 指数:132论文数:1,694被引数:8.7万
J
Jessica Cades
H 指数:9论文数:60被引数:572
S
Sanja Đačić
H 指数:72论文数:319被引数:2.6万
H
Hailun Wang
H 指数:24论文数:139被引数:3,379